LRF Virtual East Coast Lymphoma Workshop

Explore vFairs Space and Exhibit Hall

LRF Overview

Sarah Quinlan, LRF

Overview of Lymphoma

Pamela Allen, MD, Emory University

Update on COVID-19

Peter Martin, MD, Weill Cornell/New York Presbyterian

30 minute Q&A with both speakers

Pamela Allen, MD and Peter Martin, MD

Networking Lounge and Exhibit Hall

Breakout Sessions: Disease-Specific

• Aggressive B-Cell Non-Hodgkin Lymphomas: Newly Diagnosed Adam Olszewski MD, Lifespan Cancer Institute of Rhode Island
• Aggressive B-Cell Non-Hodgkin Lymphomas: Relapsed/Refractory Kieron Dunleavy, MD, Georgetown University
• Aggressive T-Cell Lymphomas Jia Ruan, MD, Weill Cornell/New York Presbyterian
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Newly Diagnosed (CLL/SLL) Jonathan Allan, MD, Weill Cornell/New York Presbyterian
• Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Relapsed/Refractory (CLL/SLL)Anthony Mato, MD, Memorial Sloan Kettering Cancer Center
• Cutaneous T-Cell Lymphomas Pierluigi Porcu, MD, Jefferson University Hospitals
• Follicular Non-Hodgkin Lymphoma and Marginal Zone Lymphoma: Newly DiagnosedJean Koff, MD, Emory University
• Follicular Lymphoma and Marginal Zone Lymphoma: Relapsed/RefractoryJakub Svoboda, MD, University of Pennsylvania
• Hodgkin Lymphoma Celeste Bello, MD, Moffitt, Cancer Center
• Mantle Cell Lymphoma: Newly Diagnosed Anita Kumar, MD, Memorial Sloan Kettering Cancer Center
• Mantle Cell Lymphoma: Relapsed/RefractoryJonathon Cohen, MD, Emory University
• Waldenström Macroglobulinemia Shayna Sarosiek, MD, Dana-Farber Cancer Institute

Networking Lounge and Exhibit Hall

Living with Lymphoma Breakouts

• Lymphoma SurvivorshipAndrea Sitlinger, MD, Duke Cancer Center
• NutritionHolly Mills, MS, RD, CSO, John Theurer Cancer Center
• Health Insurance and Employment – Avoiding Financial Toxicity and HardshipsTriage Cancer

Immunotherapy and CAR T Cell Therapy

Matthew McKinney, MD, Duke University

Workshop Concludes